Using mindfulness to lower blood pressure in patients with chronic kidney disease
Sympatho-inhibition with Mindfulness in Chronic Kidney Disease
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-10899744
This study is looking at how mindfulness meditation can help lower blood pressure and boost heart health for people with chronic kidney disease, offering a gentle alternative to medications that might have unwanted side effects.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10899744 on ClinicalTrials.gov |
What this research studies
This research investigates how mindfulness meditation can help reduce blood pressure and improve heart health in patients with chronic kidney disease (CKD). It focuses on the overactive sympathetic nervous system, which contributes to high blood pressure and cardiovascular risks in CKD patients. By employing mindfulness-based stress reduction techniques, the study aims to provide a safe and effective alternative to traditional medications that often have undesirable side effects. Participants will engage in mindfulness practices while researchers measure their blood pressure and autonomic nervous system responses to assess the effectiveness of this approach.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic kidney disease who experience high blood pressure and are seeking alternative treatment options.
Not a fit: Patients with acute kidney injury or those who do not have chronic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could offer CKD patients a non-pharmacological method to manage their blood pressure and reduce cardiovascular risks.
How similar studies have performed: Previous studies have shown that mindfulness meditation can effectively lower blood pressure in various patient populations, suggesting potential success for this approach in CKD patients.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PARK, JEANIE — EMORY UNIVERSITY
- Study coordinator: PARK, JEANIE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.